Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

Cancelled under Section 30(1)(c) of the Act

Clear all

24849 result(s) found, displaying 301 to 325

CIPLA PREGABALIN pregabalin 75 mg capsule blister Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
CIPLA PREGABALIN pregabalin150 mg capsule blister Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
Clear Vision 5000 plus Bilberry and Lutein V2 Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Nature's Care Manufacture Pty Limited
Clements Energy and Focus Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Felton Grimwade & Bosisto's Pty Ltd
Clements Iron Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Felton Grimwade & Bosisto's Pty Ltd
COBRA Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Vitex Pharmaceuticals Pty Ltd
Cold Sore Plus Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Australian Naturalcare Products Pty Ltd
Collagen Plus Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Skinstitut Australia Pty Ltd
CoQ10 Bio-Boost 50mg Vege Cap Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Homart Pharmaceuticals Pty Ltd
Cordyceps + Ganoderma 2 in 1 Formula Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Ausway Pharmaceutical Pty Ltd
Cranberry 30000 Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Me Today AU Pty Ltd
Cranberry 35,000mg Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Australian Naturalcare Products Pty Ltd
Creatine Gummy Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Emrald Labs Pty Ltd
CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (0.8 g/5 mL), Injection Solution Vial for Subcutaneous Use Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by CSL Behring (Australia) Pty Ltd
CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (1.6 g/10 mL), Injection Solution Vial for Subcutaneous Use Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by CSL Behring (Australia) Pty Ltd
CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (3.2 g/20 mL), Injection Solution Vial for Subcutaneous Use Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by CSL Behring (Australia) Pty Ltd
Dermacare Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Sunshine Australia Enterprises Pty Ltd
Dermalogica Oil Free Matte SPF30 Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Dermalogica Pty Ltd
Digestive Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Advanced Biotherapeutics Pty Ltd
Digestive Support Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Rawleigh Healthcare Pty Ltd
DISPRIN LOW DOSE ASPIRIN 100mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Reckitt Benckiser Pty Ltd
DOCETAXEL ASTRON 160 mg/8 mL docetaxel concentrated injection 160 mg/8 mL glass vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
DOCETAXEL ASTRON 20 mg/1 mL docetaxel concentrated injection 20 mg/1 mL glass vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
DOCETAXEL ASTRON 80 mg/4 mL docetaxel concentrated injection 80 mg/4 mL glass vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
DRAXIMAGE MAA kit for the preparation of Technetium Tc 99m Albumin Aggregated Injection Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

CIPLA PREGABALIN pregabalin 75 mg capsule blister Cancelled under Section 30(1)(c) of the Act

CIPLA PREGABALIN pregabalin150 mg capsule blister Cancelled under Section 30(1)(c) of the Act

Clear Vision 5000 plus Bilberry and Lutein V2 Cancelled under Section 30(1)(c) of the Act

Clements Energy and Focus Cancelled under Section 30(1)(c) of the Act

Clements Iron Cancelled under Section 30(1)(c) of the Act

COBRA Cancelled under Section 30(1)(c) of the Act

Cold Sore Plus Cancelled under Section 30(1)(c) of the Act

Collagen Plus Cancelled under Section 30(1)(c) of the Act

CoQ10 Bio-Boost 50mg Vege Cap Cancelled under Section 30(1)(c) of the Act

Cordyceps + Ganoderma 2 in 1 Formula Cancelled under Section 30(1)(c) of the Act

Cranberry 30000 Cancelled under Section 30(1)(c) of the Act

Cranberry 35,000mg Cancelled under Section 30(1)(c) of the Act

Creatine Gummy Cancelled under Section 30(1)(c) of the Act

CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (0.8 g/5 mL), Injection Solution Vial for Subcutaneous Use Cancelled under Section 30(1)(c) of the Act

CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (1.6 g/10 mL), Injection Solution Vial for Subcutaneous Use Cancelled under Section 30(1)(c) of the Act

CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (3.2 g/20 mL), Injection Solution Vial for Subcutaneous Use Cancelled under Section 30(1)(c) of the Act

Dermacare Cancelled under Section 30(1)(c) of the Act

Dermalogica Oil Free Matte SPF30 Cancelled under Section 30(1)(c) of the Act

Digestive Cancelled under Section 30(1)(c) of the Act

Digestive Support Cancelled under Section 30(1)(c) of the Act

DISPRIN LOW DOSE ASPIRIN 100mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

DOCETAXEL ASTRON 160 mg/8 mL docetaxel concentrated injection 160 mg/8 mL glass vial Cancelled under Section 30(1)(c) of the Act

DOCETAXEL ASTRON 20 mg/1 mL docetaxel concentrated injection 20 mg/1 mL glass vial Cancelled under Section 30(1)(c) of the Act

DOCETAXEL ASTRON 80 mg/4 mL docetaxel concentrated injection 80 mg/4 mL glass vial Cancelled under Section 30(1)(c) of the Act

DRAXIMAGE MAA kit for the preparation of Technetium Tc 99m Albumin Aggregated Injection Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?